102 results on '"Filice E"'
Search Results
2. The innovative “Bio-Oil Spread” prevents metabolic disorders and mediates preconditioning-like cardioprotection in rats
- Author
-
Quintieri, A.M., Filice, E., Amelio, D., Pasqua, T., Lupi, F.R., Scavello, F., Cantafio, P., Rocca, C., Lauria, A., Penna, C., De Cindio, B., Cerra, M.C., and Angelone, T.
- Published
- 2016
- Full Text
- View/download PDF
3. The NO stimulator, Catestatin, improves the Frank–Starling response in normotensive and hypertensive rat hearts
- Author
-
Angelone, T., Quintieri, A.M., Pasqua, T., Filice, E., Cantafio, P., Scavello, F., Rocca, C., Mahata, S.K., Gattuso, A., and Cerra, M.C.
- Published
- 2015
- Full Text
- View/download PDF
4. Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart
- Author
-
Angelone, T., Filice, E., Quintieri, A.M., Imbrogno, S., Amodio, N., Pasqua, T., Pellegrino, D., Mulè, F., and Cerra, M.C.
- Published
- 2012
- Full Text
- View/download PDF
5. Distinct signalling mechanisms are involved in the dissimilar myocardial and coronary effects elicited by quercetin and myricetin, two red wine flavonols
- Author
-
Angelone, T., Pasqua, T., Di Majo, D., Quintieri, A.M., Filice, E., Amodio, N., Tota, B., Giammanco, M., and Cerra, M.C.
- Published
- 2011
- Full Text
- View/download PDF
6. How to manage children if a second wave of COVID-19 occurs
- Author
-
Esposito S., Zona S., Vergine G., Fantini M., Marchetti F., Stella M., Valletta E., Biasucci G., Lanari M., Dodi I., Bigi M., Magista A. M., Vaienti F., Cella A., Affanni P., Re M. C., Sambri V., Principi N., Ancora G., Rizzi S., Greco M., Iacono A., Turla G., Angelini R., Filice E., Fugetto F., Cortina I., Mystkowsky R., Veronesi L., Colucci M. E., Rubini M., Maffini V., Perrone S., Castellone E., Esposito S., Zona S., Vergine G., Fantini M., Marchetti F., Stella M., Valletta E., Biasucci G., Lanari M., Dodi I., Bigi M., Magista A.M., Vaienti F., Cella A., Affanni P., Re M.C., Sambri V., Principi N., Ancora G., Rizzi S., Greco M., Iacono A., Turla G., Angelini R., Filice E., Fugetto F., Cortina I., Mystkowsky R., Veronesi L., Colucci M.E., Rubini M., Maffini V., Perrone S., and Castellone E.
- Subjects
Pulmonary and Respiratory Medicine ,2019-20 coronavirus outbreak ,Infectious Diseases ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MEDLINE ,Medicine ,COVID-19, Children ,business ,Virology - Abstract
NION DISPONIBILE
- Published
- 2020
7. Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia/reperfusion injury
- Author
-
Angelone, T., Filice, E., Pasqua, T., Amodio, N., Galluccio, M., Montesanti, G., Quintieri, A. M., and Cerra, M. C.
- Published
- 2013
- Full Text
- View/download PDF
8. β3-Adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway
- Author
-
Angelone, T., Filice, E., Quintieri, A. M., Imbrogno, S., Recchia, A., Pulerà, E., Mannarino, C., Pellegrino, D., and Cerra, M. C.
- Published
- 2008
9. Manipulating the sequence of food ingestion improves glycemic control in type 2 diabetic patients under free-living conditions
- Author
-
Tricò, Domenico, Filice, E, Trifirò, Silvia, and Natali, Andrea
- Subjects
Blood Glucose ,Male ,medicine.medical_specialty ,Glycated Hemoglobin A ,Endocrinology, Diabetes and Metabolism ,Short Communication ,030209 endocrinology & metabolism ,Type 2 diabetes ,030204 cardiovascular system & hematology ,Kidney ,03 medical and health sciences ,Endocrinology ,0302 clinical medicine ,Internal medicine ,Diabetes mellitus ,Diabetes Mellitus ,Internal Medicine ,medicine ,Ingestion ,Humans ,Glycemic ,Aged ,Glycated Hemoglobin ,Meal ,business.industry ,Fasting ,Feeding Behavior ,Middle Aged ,medicine.disease ,Postprandial Period ,Diabetes and Metabolism ,Postprandial ,Treatment Outcome ,Diabetes Mellitus, Type 2 ,Liver ,Hyperglycemia ,Female ,Waist Circumference ,medicine.symptom ,Metabolic syndrome ,business ,Weight gain ,Type 2 - Abstract
Lipid and protein ingested before carbohydrate reduce postprandial hyperglycemia. We tested feasibility, safety and clinical efficacy of manipulating the sequence of nutrient ingestion in patients with type 2 diabetes (T2D). After a 4-week run-in, 17 T2D patients were randomized to either a control diet (CD) or to an experimental diet (ED) allowing the consumption of high-carbohydrate foods only after high-protein and high-fat foods at each main meal (lunch+dinner). Both diets were accurately followed and neutral on arterial blood pressure, plasma lipids and indices of hepatic and kidney function. After 8 weeks, in spite of a similar reduction of body weight (ED −1.9 95% confidence interval (−3.4/−0.4)kg, PPPPP−1, P−1, P−1, P−1, PPPP
- Published
- 2016
10. Sustained effects of a protein and lipid preload on glucose tolerance in type 2 diabetes patients
- Author
-
Tricò, Domenico, Filice, E., Baldi, Simona, Frascerra, Silvia, Mari, A., and Natali, Andrea
- Subjects
Blood Glucose ,Male ,Time Factors ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Type 2 diabetes ,030204 cardiovascular system & hematology ,Beta-cell function ,Glucose absorption ,Insulin secretion in vivo ,Nutrient preload ,Internal Medicine ,Endocrinology ,0302 clinical medicine ,Adult ,Aged ,Diabetes Mellitus, Type 2 ,Dietary Fats ,Dietary Proteins ,Female ,Glucose ,Glucose Intolerance ,Glucose Tolerance Test ,Humans ,Middle Aged ,Postprandial Period ,A protein ,General Medicine ,Glucagon-like peptide-1 ,Diabetes and Metabolism ,Boiled egg ,Type 2 ,medicine.medical_specialty ,030209 endocrinology & metabolism ,Biology ,03 medical and health sciences ,food ,Internal medicine ,medicine ,Diabetes Mellitus ,Insulin ,medicine.disease ,food.food ,Bioavailability ,Preload ,Homeostasis - Abstract
Small amounts of nutrients given as a 'preload' can reduce post-meal hyperglycaemic peaks in type 2 diabetes (T2D) patients by activating a number of mechanisms involved in glucose homoeostasis. This study was undertaken to ascertain whether this positive effect extends to the late absorptive phase and to identify the main mechanisms involved.Eight well-controlled T2D patients, aged 40-70 years, were randomized to consume a 'preload' of either water or non-glucidic nutrients (50g of Parmesan cheese, one boiled egg) 30min before a 300-min oral glucose tolerance test.After the nutrient preload, significant reductions were observed in peak glucose (-49%; P0.02), total plasma glucose (iAUC: -28%; P0.03), exogenous glucose (iAUC: -30%; P0.03) and insulin clearance (-28%; P0.04), with enhancement of insulin secretion (iAUC: +22%; P0.003). These effects were associated with higher plasma levels of GLP-1 (iAUC: +463%; P0.002), GIP (iAUC: +152%; P0.0003) and glucagon (iAUC: +144%; P0.0002).In T2D patients, a protein and lipid preload improves glucose tolerance throughout the whole post-absorptive phase mainly by reducing the appearance of oral glucose, and improving both beta-cell function and insulin bioavailability.
- Published
- 2016
11. Myocardial and coronary functions of glucagon-like peptide-2 in the rat heart
- Author
-
Angelone, T, Filice, E, Quintieri, A, Imbrogno, S, Vitetti, A, Veltri, A, Pellegrono, D, Cerra, MC, MULE', Flavia, Angelone, T, Filice, E, Quintieri, A, Imbrogno, S, Vitetti, A, Veltri, A, Pellegrono, D, Mulè, F, and Cerra, MC
- Subjects
Gut peptides, cardiac perfirmance ,Settore BIO/09 - Fisiologia - Published
- 2010
12. The emerging myocardial and coronary action of Glucagon-derived peptide-2
- Author
-
Angelone, T, Pasqua, T, Filice, E, Quintieri, AM, Imbrogno, S, Amodio, N, Pellegrino, D, Cerra, MC, MULE', Flavia, Angelone, T, Pasqua, T, Filice, E, Quintieri, AM, Imbrogno, S, Amodio, N, Pellegrino, D, Mulè, F, and Cerra, MC
- Subjects
Settore BIO/09 - Fisiologia ,gut peptides, cardiac performance - Published
- 2010
13. Manipulating the sequence of food ingestion improves glycemic control in type 2 diabetic patients under free-living conditions
- Author
-
Tricò, D, primary, Filice, E, additional, Trifirò, S, additional, and Natali, A, additional
- Published
- 2016
- Full Text
- View/download PDF
14. Pre-conditioning cardioprotection mediated by the estrogen receptors in spontaneously hypertensive female rats
- Author
-
Angelone, T., primary, Penna, C., additional, De Francesco, E.M., additional, Pasqua, T., additional, Rocca, C., additional, Cantafio, P., additional, Femminò, S., additional, Filice, E., additional, Pagliaro, P., additional, Maggiolini, M., additional, and Cerra, M.C., additional
- Published
- 2015
- Full Text
- View/download PDF
15. Rat ChromograninA 1-64 (rCGA1-64): novel autocrine/paracrine hormone for myocardial and coronary regulation in the rat heart
- Author
-
Quintieri, Am, Angelone, T, Pulera’, E, Filice, E, METZ BOUTIGUE, M. H., Alloatti, Giuseppe, Tota, B, and Cerra, Mc
- Published
- 2007
16. Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia/reperfusion injury
- Author
-
Angelone, T., primary, Filice, E., additional, Pasqua, T., additional, Amodio, N., additional, Galluccio, M., additional, Montesanti, G., additional, Quintieri, A. M., additional, and Cerra, M. C., additional
- Published
- 2012
- Full Text
- View/download PDF
17. Temporal and spatial occurrence of landsliding and correlation with precipitation time series in Montalto Uffugo (Calabria) and Imera (Sicilia) areas
- Author
-
Sorriso-Valvo M., Agnesi V., Gullà G., Merenda L., Antronico L., Di Maggio C., Filice E., Petrucci O., and Tansi C.
- Published
- 1994
18. The homologous rat chromogranin A1‐64 (rCGA1‐64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium‐derived nitric oxide
- Author
-
Cerra, M. C., primary, Gallo, M. P., additional, Angelone, T., additional, Quintieri, A. M., additional, Pulerà, E., additional, Filice, E., additional, Guérold, B., additional, Shooshtarizadeh, P., additional, Levi, R., additional, Ramella, R., additional, Brero, A., additional, Boero, O., additional, Metz‐Boutigue, M. H., additional, Tota, B., additional, and Alloatti, G., additional
- Published
- 2008
- Full Text
- View/download PDF
19. 17β-Estradiol modulation of male rat cardiac performance: Inotropism and mechanism of action
- Author
-
Filice, E., primary, Recchia, A., additional, Pellegrino, D., additional, Angelone, T., additional, Maggiolini, M., additional, and Cerra, M.C., additional
- Published
- 2008
- Full Text
- View/download PDF
20. Negative inotropic and lusitropic actions of catestatin on isolated rat heart: Potential therapy for hypertensive cardiomyopathy
- Author
-
Quintieri, A.M., primary, Angelone, T., additional, Filice, E., additional, Mahata, S.K., additional, Tota, B., additional, and Cerra, M.C., additional
- Published
- 2008
- Full Text
- View/download PDF
21. Cardiac cytoskeleton is modulated by human recombinant Vasostatin 1
- Author
-
Angelone, T., primary, Mazza, R., additional, Mannarino, C., additional, Filice, E., additional, Barbieri, S., additional, Goumon, Y., additional, Zummo, G., additional, Metz-Boutigue, M.-H., additional, and Tota, B., additional
- Published
- 2007
- Full Text
- View/download PDF
22. Beta3-adrenoceptors mediate negative lusitropism via NO-cGMP-PKG pathway
- Author
-
Filice, E., primary, Angelone, T., additional, Imbrogno, S., additional, Pellegrino, D., additional, Adamo, C., additional, Gattuso, A., additional, and Cerra, M.C., additional
- Published
- 2007
- Full Text
- View/download PDF
23. WITHDRAWN: Cardiac cytoskeleton is modulated by human recombinant vasostatin 1
- Author
-
Angelone, T., primary, Mazza, R., additional, Mannarino, C., additional, Filice, E., additional, Barbieri, S., additional, Goumon, Y., additional, Zummo, G., additional, Metz-Boutigue, M.-H., additional, and Tota, B., additional
- Published
- 2007
- Full Text
- View/download PDF
24. WITHDRAWN: Cardiac cytoskeleton is modulated by human recombinant vasostatin 1
- Author
-
Angelone, T., Mazza, R., Mannarino, C., Filice, E., Barbieri, S., Goumon, Y., Zummo, G., Metz-Boutigue, M.-H., and Tota, B.
- Published
- 2006
- Full Text
- View/download PDF
25. β3-Adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway.
- Author
-
Angelone, T., Filice, E., Quintieri, A. M., Imbrogno, S., Recchia, A., Pulerá, E., Mannarino, C., Pellegrino, D., and Cerra, M. C.
- Subjects
- *
ADRENERGIC receptors , *BETA adrenoceptors , *HEART , *RATS , *LABORATORY animals , *NITRIC oxide - Abstract
Aims: Using a model of isolated and Langendorff-perfused rat heart we analysed whether activation of β3-adrenergic receptors (β3-ARs) influences ventricular lusitropic performance. We also focused on the NOS/NO/cGMP/PKG cascade as the signal transduction mechanism. Methods: Hearts were treated with increasing concentrations (from 10−12 to 10−6 m) of BRL37344, a selective β3-AR agonist, and cardiac performance was evaluated by analysing both lusitropic parameters and coronary motility. Cardiac preparations were also perfused with BRL37344 in the presence of either isoproterenol (ISO) or nadolol, or pertussis toxin (PTx), or selective inhibitors of the NOS/NO/cGMP/PKG pathway. Results: BRL37344 caused a significant concentration-dependent reduction in (LVd P/d t)min, a decrease in half time relaxation significant starting from 10−12 m, and an increase in (LVd P/d t)max/(LVd P/d t)min ratio ( T/− t). BRL37344 abolished the ISO-mediated positive lusitropism. β3-AR-dependent effects on relaxation were insensitive to β1/β2-AR inhibition by nadolol (100 nm), and were abolished by Gi/o protein inhibition by PTx (0.01 nm). NO scavenging by haemoglobin (10 μm), and nitric oxide synthase (NOS) inhibition by NG-monomethyl-l-arginine (10 μm) revealed the involvement of NO signalling in BRL37344 response. Pre-treatment with inhibitors of either soluble guanylate cyclase (ODQ; 10 μm) or PKG (KT5823; 100 nm) abolished β3-AR-dependent negative lusitropism. In contrast, anantin (10 nm), an inhibitor of particulate guanylate cyclase, did not modify the effect of BRL37344 on relaxation. Conclusion: Taken together, our findings provide functional evidence for β3-AR modulation of ventricular relaxation in the rat heart which involves PTx-sensitive inhibitory Gi protein and occurs via an NO-cGMP-PKG cascade. Whether the effects of β3-AR stimulation on lusitropism are beneficial or detrimental remains to be established. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
26. A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat
- Author
-
Filice, E., Recchia, A. G., Daniela Pellegrino, Angelone, T., Maggiolini, M., and Cerra, M. C.
- Subjects
Male ,Dose-Response Relationship, Drug ,Estradiol ,Nitric Oxide Synthase Type III ,Estrogen Receptor alpha ,Gene Expression ,Heart ,GTP-Binding Protein alpha Subunits, Gi-Go ,In Vitro Techniques ,Cyclic AMP-Dependent Protein Kinases ,Rats ,Receptors, G-Protein-Coupled ,Heart Rate ,Ventricular Pressure ,Animals ,Estrogen Receptor beta ,RNA, Messenger ,Rats, Wistar ,Extracellular Signal-Regulated MAP Kinases ,Phosphoinositide-3 Kinase Inhibitors ,Signal Transduction - Abstract
In the present study, we evaluated the transduction pathways involved in the cardiac effects elicited by 17beta-estradiol (E2) on the isolated, Langendorff perfused male Wistar rat heart. E2 and selective agonists for ERalpha and ERbeta induced a dose-dependent reduction of contractility which was blocked by the ER inhibitor ICI 182,780. Moreover, the potential involvement of the novel membrane estrogen receptor GPR30 in mediating estrogen activity was determined using the selective GPR30 ligand G-1. Notably, specific inhibitors of ERK, PI3K, PKA, and eNOS transduction pathways abolished the cardiac responses to E(2). Taken together, our data suggest that ERalpha and ERbeta along with several signaling cascades are involved in the action of E(2) on the male rat heart. Our results also point to a potential role of GPR30, however further evaluation is required in order to fully understand the contribution of the different estrogen receptors in mediating estrogen activity on cardiac performance.
27. Circulating Endothelial Cells: A New Possible Marker of Endothelial Damage in Kawasaki Disease, Multisystem Inflammatory Syndrome in Children and Acute SARS-CoV-2 Infection
- Author
-
Marianna Fabi, Biljana Petrovic, Laura Andreozzi, Elena Corinaldesi, Emanuele Filice, Carlotta Biagi, Alessia Rizzello, Bianca Elisa Mattesini, Simone Bugani, Marcello Lanari, Fabi M., Petrovic B., Andreozzi L., Corinaldesi E., Filice E., Biagi C., Rizzello A., Mattesini B.E., Bugani S., and Lanari M.
- Subjects
kawasaki disease ,multisystem inflammatory syndrome in children ,CellSearch ,circulating endothelial cells ,COVID-19 ,children ,endothelial injury ,coronary artery lesions ,Mucocutaneous Lymph Node Syndrome ,coronary artery lesion ,Catalysis ,Inorganic Chemistry ,circulating endothelial cell ,Humans ,Prospective Studies ,Physical and Theoretical Chemistry ,Child ,Molecular Biology ,Spectroscopy ,Endothelial Cell ,SARS-CoV-2 ,Organic Chemistry ,Endothelial Cells ,Biomarker ,General Medicine ,Vascular System Injuries ,Systemic Inflammatory Response Syndrome ,Computer Science Applications ,Prospective Studie ,Biomarkers ,Human - Abstract
Background: Kawasaki Disease (KD) and Multisystem Inflammatory Syndrome in Children (MIS-C) are pediatric diseases characterized by systemic inflammation and vascular injury, potentially leading to coronary artery lesions (CALs). Data on vascular injury occurring during acute COVID-19 (AC19) in children are still lacking. The aim of our study was to investigate endothelial injury in KD-, MIS-C- and AC19-dosing circulating endothelial cells (CECs). Methods: We conducted a multicenter prospective study. CECs were enumerated by CellSearch technology through the immunomagnetic capture of CD146-positive cells from whole blood. Results: We enrolled 9 KD, 20 MIS-C and 10 AC19. During the acute stage, the AC19 and KD patients had higher CECs levels than the MIS-C patients. From the acute to subacute phase, a significant CEC increase was observed in the KD patients, while a mild decrease was detected in the MIS-C patients. Cellular clusters/syncytia were more common in the KD patients. No correlation between CECs and CALs were found in the MIS-C patients. The incidence of CALs in the KD group was too low to investigate this correlation. Conclusions: Our study suggests a possible role of CECs as biomarkers of systemic inflammation and endothelial dysfunction in KD and MIS-C and different mechanisms of vascular injury in these diseases. Further larger studies are needed.
- Published
- 2022
28. Combination of fecal calprotectin and initial coronary dimensions to predict coronary artery lesions persistence in Kawasaki disease
- Author
-
Marianna Fabi, Emanuele Filice, Laura Andreozzi, Bianca Elisa Mattesini, Alessia Rizzello, Daniela Palleri, Elton Dajti, Rocco Maurizio Zagari, Marcello Lanari, Fabi M., Filice E., Andreozzi L., Mattesini B.E., Rizzello A., Palleri D., Dajti E., Zagari R.M., and Lanari M.
- Subjects
Male ,Multidisciplinary ,Immunoglobulins, Intravenous ,Infant ,Coronary Artery Disease ,Mucocutaneous Lymph Node Syndrome ,Coronary Vessels ,Prospective Studie ,C-Reactive Protein ,Immunoglobulins, Intravenou ,Child, Preschool ,Humans ,Female ,Prospective Studies ,Child ,Leukocyte L1 Antigen Complex ,Coronary Vessel ,Human - Abstract
Kawasaki Disease (KD) is systemic vasculitis involving medium-sized vessels in children. The aim of our study is to determine if fecal calprotectin (FC) could be useful in predicting the development or persistence of coronary artery lesions (CALs) in KD. We conducted a prospective monocentric study including all consecutive diagnoses of. Clinical, laboratory, echocardiographic data were recorded during the acute and subacute phase, including FC. Correlations among laboratory values, FC, clinical manifestations, IVIG-responsiveness and CALs development were investigated. We enrolled 26 children (76.9% boys; median age 34.5 months). The combination of FC > 250 microg/g and z-score > 2 during the acute phase was associated with the persistence of CALs (p = 0.022). A z-score > 2 alone during the acute phase was not related to CALs during the subacute stage (p > 0.05). A neutrophil percentage > 70% and WBC > 15,000/mmc during the acute phase significantly correlated with the presence of CALs during the subacute phase (p = 0.008). C-reactive protein (CRP) > 13 mg/dL at KD onset was significantly associated with the presence of CALs during the acute (p = 0.017) and subacute phase (p = 0.001). The combination of FC > 250 microg/g and a z-score > 2 during the acute phase of KD may be used as a predictor of CALs persistence. It can be useful especially in children with an initial CRP
- Published
- 2021
29. Morbid Obesity and Thyroid Cancer Rate. A Review of Literature
- Author
-
Vincenzo Schiavone, Giovanna Berardi, Mario Musella, Silvia Savastano, Antonio Vitiello, Emanuele Filice, Nunzio Velotti, Stefania Masone, Rossana Serao, Masone, S., Velotti, N., Savastano, S., Filice, E., Serao, R., Vitiello, A., Berardi, G., Schiavone, V., and Musella, M.
- Subjects
Oncology ,medicine.medical_specialty ,obesity ,chronic inflammation ,Population ,Adipokine ,Review ,Overweight ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Hyperinsulinemia ,thyroid cancer ,education ,Thyroid cancer ,Protein kinase B ,adipokines ,030304 developmental biology ,0303 health sciences ,education.field_of_study ,business.industry ,Cancer ,General Medicine ,medicine.disease ,030220 oncology & carcinogenesis ,Medicine ,medicine.symptom ,business ,Body mass index - Abstract
In the past three decades, several recent studies have analyzed the alarming increase of obesity worldwide, and it has been well established that the risk of many types of malignancies is increased in obese individuals; in the same period, thyroid cancer has become the fastest growing cancer of all malignancies. We investigated the current literature to underline the presence of a connection between excess body weight or Body Mass Index (BMI) and risk of thyroid cancer. Previous studies stated that the contraposition between adipocytes and adipose-resident immune cells enhances immune cell production of multiple pro-inflammatory factors with subsequent induction of hyperlipidemia and vascular injury; these factors are all associated with oxidative stress and cancer development and/or progression. Moreover, recent studies made clear the mitogenic and tumorigenic action of insulin, carried out through the stimulation of mitogen-activated protein kinase (MAPK) and phosphoinositide-3 kinase/AKT (PI3K/AKT) pathways, which is correlated to the hyperinsulinemia and hyperglycemia found in obese population. Our findings suggest that obesity and excess body weight are related to an increased risk of thyroid cancer and that the mechanisms that combine overweight with this cancer should be searched for in the adipokine pathways and chronic inflammation onset.
- Published
- 2021
30. Mast cell activation disorders
- Author
-
Arianna Giannetti, Andrea Pession, Carlo Caffarelli, Giampaolo Ricci, Emanuele Filice, Giannetti A., Filice E., Caffarelli C., Ricci G., and Pession A.
- Subjects
Medicine (General) ,9 alpha,11 beta-prostaglandin F2α ,1,4-methylhistamine ,Tryptase ,Mast cell activation syndrome ,Review ,Disease ,Urinary leukotriene E4 ,Mast cell ,Diagnosis, Differential ,R5-920 ,Humans ,Medicine ,Mast Cells ,N-methylhistamine ,Child ,9 alpha,11 beta- prostaglandin F2α ,mastocytosis ,biology ,business.industry ,Mast cell activation ,Mastocytosi ,Degranulation ,Syndrome ,General Medicine ,Review article ,C-Kit ,medicine.anatomical_structure ,Immunology ,biology.protein ,Hereditary alpha-tryptasemia ,medicine.symptom ,Differential diagnosis ,business ,Biomarkers - Abstract
Background and Objectives: Mast cell disorders comprise a wide spectrum of syndromes caused by mast cells’ degranulation with acute or chronic clinical manifestations. Materials and Methods: In this review article we reviewed the latest findings in scientific papers about mast cell disorders with a particular focus on mast cell activation syndrome and mastocytosis in pediatric age. Results: Patients with mast cell activation syndrome have a normal number of mast cells that are hyperreactive upon stimulation of various triggers. We tried to emphasize the diagnostic criteria, differential diagnosis, and therapeutic strategies. Another primary mast cell disorder is mastocytosis, a condition with a long-known disease, in which patients have an increased number of mast cells that accumulate in different regions of the body with different clinical evolution in pediatric age. Conclusions: Mast cell activation syndrome overlaps with different clinical entities. No consensus was found on biomarkers and no clearly resolutive treatment is available. Therefore, a more detailed knowledge of this syndrome is of fundamental importance for a correct diagnosis and effective therapy.
- Published
- 2021
31. Multisystem inflammatory syndrome following sars-cov-2 infection in children: One year after the onset of the pandemic in a high-incidence area
- Author
-
Marianna Fabi, Chiara Ghizzi, Alessandro De Fanti, Bianca Elisa Mattesini, Liliana Gabrielli, Laura Andreozzi, Marcello Lanari, Alessia Rizzello, Carlotta Biagi, Daniela Palleri, Daniela Di Luca, Fabio Caramelli, Emanuele Filice, Fabi M., Filice E., Biagi C., Andreozzi L., Palleri D., Mattesini B.E., Rizzello A., Gabrielli L., Ghizzi C., Di Luca D., Caramelli F., De Fanti A., and Lanari M.
- Subjects
Inotrope ,Male ,medicine.medical_specialty ,Multisystem inflammatory syndrome in childhood ,Adolescent ,Disease ,Mucocutaneous Lymph Node Syndrome ,Microbiology ,Article ,Ventricular Dysfunction, Left ,Virology ,Internal medicine ,medicine ,Humans ,Prospective Studies ,Kawasaki Disease ,Prospective cohort study ,Child ,Cross-Sectional Studie ,biology ,Cardiac involvement ,business.industry ,SARS-CoV-2 ,Incidence (epidemiology) ,Myocardium ,Interleukin-8 ,Cytokine profiles ,Infant, Newborn ,COVID-19 ,Infant ,medicine.disease ,Troponin ,QR1-502 ,Infliximab ,Systemic Inflammatory Response Syndrome ,Cytokine profile ,Interleukin-10 ,Systemic inflammatory response syndrome ,Prospective Studie ,Infectious Diseases ,Cross-Sectional Studies ,Italy ,Child, Preschool ,biology.protein ,Kawasaki disease ,Female ,business ,Human ,medicine.drug - Abstract
SARS-CoV-2 infection in children can trigger cardiovascular manifestations potentially requiring an intensive treatment and defining a new entity named Multisystem Inflammatory Syndrome in Children (MIS-C), whose features partially overlap with Kawasaki Disease (KD). A cross-sectional study including all diagnoses of MIS-C and KD from April 2020 to May 2021 in our metropolitan area was conducted evaluating clinical, laboratory (including immunological response, cytokines, and markers of myocardial damage), and cardiac (coronary and non-coronary) features at onset of the diseases. Evolution of ventricular dysfunction, valve regurgitations, and coronary lesions was documented. The severity of the disease was also considered based on the need for inotropic support and ICU admission. Twenty-four MIS-C were diagnosed (14 boys, median age 82 months): 13/24 cases (54.17%) presented left ventricular dysfunction, 12/24 (50%) required inotropic support, and 10/24 (41.67%) developed coronary anomalies (CALs). All patients received steroids and IVIG at a median time of 5 days (IQR1:4, IQR3:6.5) from onset of fever and heart function normalized 6 days (IQR1: 5, IQR3: 7) after therapy, while CALs persisted in one. One patient (12.5%) required infliximab because of refractory disease and still presented CALs 18 days after therapy. During the same study period, 15 KD were diagnosed: none had ventricular dysfunction, while 7/15 (46.67%) developed CALs. Three out of 15 patients (20%) still presented CALs 46 days from onset. Compared to KD, MIS-C pts have significantly higher IL8 and similar lymphocytes subpopulations. Despite a more severe presentation and initial cardiac findings compared to KD, the myocardial injury in MIS-C has a rapid response to immunomodulatory treatment (median time 6 days), in terms of ventricular function, valve regurgitations, and troponin. Incidence of CALs is similar at onset, but it tends to regress in most of the cases of MIS-C differently than in KD where CALs persist in up to 40% in the subacute stage after treatment.
- Published
- 2021
32. Gut Microbiota Dysbiosis in Childhood Vasculitis: A Perspective Comparative Pilot Study
- Author
-
Marianna Fabi, Federica D’Amico, Silvia Turroni, Laura Andreozzi, Emanuele Filice, Patrizia Brigidi, Marcello Lanari, Fabi M., D'amico F., Turroni S., Andreozzi L., Filice E., Brigidi P., and Lanari M.
- Subjects
children ,gut microbiota ,Kawasaki disease ,dysbiosi ,intestinal inflammation ,Henoch–Schönlein purpura ,vasculitis ,dysbiosis ,abdominal involvement ,Medicine (miscellaneous) - Abstract
Kawasaki disease (KD) and Henoch–Schönlein purpura (HSP) are the most frequent vasculitis in childhood. For both, a multifactorial mechanism has been hypothesised, with an abnormal immune response in genetically predisposed children. Gut microbiota (GM) alterations might trigger the hyperimmune reaction. Our aim was to explore the GM in KD and compare it with the GM of HSP and febrile children. Children diagnosed with KD, HSP and non-KD febrile illness (F) were enrolled. GM was profiled by 16S rRNA gene sequencing and compared with the profiles of healthy children from previous studies. We enrolled 13 KD, 10 HSP and 12 F children. Their GM significantly differed from controls, with an overall reduction in the relative abundance of beneficial taxa belonging to the Ruminococcaceae and Lachnospiraceae families. Potential KD and HSP signatures were identified, including smaller amounts of Dialister in the former, and Clostridium and Akkermansia in the latter. Notably, the GM structures of KD, HSP and F patients stratified by abdominal involvement, with more severe dysbiosis in those suffering from intestinal symptoms. This is the first study analysing GM in a mostly Caucasian cohort of KD and HSP children. Our data could open up new opportunities for childhood vasculitis treatment.
- Published
- 2022
- Full Text
- View/download PDF
33. Childhood Obesity and Respiratory Diseases: Which Link?
- Author
-
Angela Miniaci, Andrea Pession, Emanuela di Palmo, Giulio Maltoni, Alessandra Cavallo, Carlo Caffarelli, Emanuele Filice, Giampaolo Ricci, Di Palmo E., Filice E., Cavallo A., Caffarelli C., Maltoni G., Miniaci A., Ricci G., and Pession A.
- Subjects
obesity ,Pediatrics ,medicine.medical_specialty ,Review ,Disease ,Gut flora ,Systemic inflammation ,leptin ,Childhood obesity ,03 medical and health sciences ,0302 clinical medicine ,children ,medicine ,030212 general & internal medicine ,Risk factor ,Asthma ,biology ,business.industry ,Airway dysanapsi ,lcsh:RJ1-570 ,OSAS ,lcsh:Pediatrics ,asthma ,medicine.disease ,biology.organism_classification ,Obesity ,adipose tissue ,respiratory tract diseases ,Obstructive sleep apnea ,030228 respiratory system ,Pediatrics, Perinatology and Child Health ,airway dysanapsis ,medicine.symptom ,business - Abstract
Prevalence of childhood obesity is progressively increasing, reaching worldwide levels of 5.6% in girls and of 7.8% in boys. Several evidences showed that obesity is a major preventable risk factor and disease modifier of some respiratory conditions such as asthma and Obstructive Sleep Apnea Syndrome (OSAS). Co-occurrence of asthma and obesity may be due to common pathogenetic factors including exposure to air pollutants and tobacco smoking, Western diet, and low Vitamin D levels. Lung growth and dysanapsis phenomenon in asthmatic obese children play a role in impaired respiratory function which appears to be different than in adults. Genes involved in both asthma and obesity have been identified, though a gene-by-environment interaction has not been properly investigated yet. The identification of modifiable environmental factors influencing gene expression through epigenetic mechanisms may change the natural history of both diseases. Another important pediatric respiratory condition associated with obesity is Sleep-Disordered Breathing (SDB), especially Obstructive Sleep Apnea Syndrome (OSAS). OSAS and obesity are linked by a bidirectional causality, where the effects of one affect the other. The factors most involved in the association between OSAS and obesity are oxidative stress, systemic inflammation, and gut microbiota. In OSAS pathogenesis, obesity’s role appears to be mainly due to mechanical factors leading to an increase of respiratory work at night-time. However, a causal link between obesity-related inflammatory state and OSAS pathogenesis still needs to be properly confirmed. To prevent obesity and its complications, family education and precocious lifestyle changes are critical. A healthy diet may lead to an improved quality of life in obese children suffering from respiratory diseases. The present review aimed to investigate the links between obesity, asthma and OSAS, focusing on the available evidence and looking for future research fields.
- Published
- 2021
- Full Text
- View/download PDF
34. Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart
- Author
-
Tommaso Angelone, M.C. Cerra, E. Filice, Daniela Pellegrino, Sandra Imbrogno, Nicola Amodio, A.M. Quintieri, Teresa Pasqua, Flavia Mulè, Angelone, T, Filice, E, Quintieri, AM, Imbrogno, S, Amodio, N, Pasqua, T, Pellegrino, D, Mulè, F, and Cerra, MC
- Subjects
Male ,endocrine system ,medicine.medical_specialty ,Cardiotonic Agents ,Nitric Oxide Synthase Type III ,MAP Kinase Signaling System ,G protein ,Endocrinology, Diabetes and Metabolism ,Blotting, Western ,Medicine (miscellaneous) ,Enzyme-Linked Immunosorbent Assay ,Stimulation ,In Vitro Techniques ,Biology ,Real-Time Polymerase Chain Reaction ,glucagon-like peptides-2, gut peptides, cardiac performance ,Settore BIO/09 - Fisiologia ,Glucagon-Like Peptide-1 Receptor ,chemistry.chemical_compound ,Internal medicine ,Cyclic AMP ,Cyclic GMP-Dependent Protein Kinases ,Glucagon-Like Peptide 2 ,Receptors, Glucagon ,medicine ,Animals ,Cyclic adenosine monophosphate ,Phosphorylation ,Rats, Wistar ,Receptor ,Nutrition and Dietetics ,digestive, oral, and skin physiology ,Heart ,Peptide Fragments ,Rats ,Phospholamban ,Endocrinology ,Gene Expression Regulation ,chemistry ,Inotropism ,Glucagon-Like Peptide-2 Receptor ,Cardiology and Cardiovascular Medicine ,cGMP-dependent protein kinase ,hormones, hormone substitutes, and hormone antagonists ,Intestinal L Cells ,Signal Transduction - Abstract
Background and aims The anorexigenic glucagon-like peptide (GLP)-2 is produced by intestinal L cells and released in response to food intake. It affects intestinal function involving G-protein-coupled receptors. To verify whether GLP-2 acts as a cardiac modulator in mammals, we analysed, in the rat heart, the expression of GLP-2 receptors and the myocardial and coronary responses to GLP-2. Methods and results GLP-2 receptors were detected on ventricular extracts by quantitative real-time polymerase chain reaction (Q-RT-PCR) and Western blotting. Cardiac GLP-2 effects were analysed on Langendorff perfused hearts. Intracellular GLP-2 signalling was investigated on Langendorff perfused hearts and by Western blotting and enzyme-linked immunosorbent assay (ELISA) on ventricular extracts. By immunoblotting and Q-RT-PCR, we revealed the expression of ventricular GLP-2 receptors. Perfusion analyses showed that GLP-2 induces positive inotropism at low concentration (10–12 mol l −1 ), and negative inotropism and lusitropism from 10 to 10 mol l −1 . It dose-dependently constricts coronaries. The negative effects of GLP-2 were independent from GLP-1 receptors, being unaffected by exendin-3 (9–39) amide. GLP-2-dependent negative action involves Gi/o proteins, associates with a reduction of intracellular cyclic adenosine monophosphate (cAMP), an increase in extracellular signal regulated kinases 1 and 2 (ERK1/2) and a decrease in phospholamban phosphorylation, but is independent from endothelial nitric oxide synthase (eNOS) and protein kinase G (PKG). Finally, GLP-2 competitively antagonised β-adrenergic stimulation. Conclusions For the first time, to our knowledge, we found that: (1) the rat heart expresses functional GLP-2 receptors; (2) GLP-2 acts on both myocardium and coronaries, negatively modulating both basal and β-adrenergic stimulated cardiac performance; and (3) GLP-2 effects are mediated by G-proteins and involve ERK1/2.
- Published
- 2012
35. Distinct signalling mechanisms are involved in the dissimilar myocardial and coronary effects elicited by quercetin and myricetin, two red wine flavonols
- Author
-
Tommaso Angelone, Bruno Tota, Danila Di Majo, Marco Giammanco, Nicola Amodio, Teresa Pasqua, M.C. Cerra, E. Filice, A.M. Quintieri, Angelone, T, Pasqua, T, Di Majo, D, Quintieri, AM, Filice, E, Amodio, N, Tota, B, Giammanco, M, and Cerra, MC
- Subjects
Male ,Vasoreactivity ,Octoxynol ,Endocrinology, Diabetes and Metabolism ,Medicine (miscellaneous) ,Wine ,Vasodilation ,In Vitro Techniques ,Pharmacology ,Settore BIO/09 - Fisiologia ,Antioxidants ,Nitric oxide ,Contractility ,chemistry.chemical_compound ,Flavonols ,Animals ,heterocyclic compounds ,Rats, Wistar ,Flavonoids ,Cardioprotection ,chemistry.chemical_classification ,Analysis of Variance ,Nutrition and Dietetics ,Chemistry ,Myocardium ,Myricetin ,food and beverages ,Heart ,Rats ,Biochemistry ,Inotropism ,Quercetin ,Myocardial contractility ,Cardiology and Cardiovascular Medicine ,Signal Transduction - Abstract
Background and Aims: Moderate red wine consumption associates with lower incidence of cardiovascular diseases. Attention to the source of this cardioprotection was focused on flavonoids, the non-alcoholic component of the red wine, whose intake inversely correlates with adverse cardiovascular events. We analysed whether two red wine flavonoids, quercetin and myricetin, affect mammalian basal myocardial and coronary function. Methods and results: Quercetin and myricetin effects were evaluated on isolated and Langendorff perfused rat hearts under both basal conditions and a- and b-adrenergic stimulation. The intracellular signalling involved in the effects of these flavonoids was analysed on perfused hearts and by western blotting on cardiac and HUVEC extracts. Quercetin induced biphasic inotropic and lusitropic effects, positive at lower concentrations and negative at higher concentrations. Contrarily, Myricetin elicits coronary dilation, without affecting contractility and relaxation. Simultaneous administration of the two flavonoids only induced vasodilation. Quercetin-elicited positive inotropism and lusitropism depend on b1/b2-adrenergic receptors and associate with increased intracellular cAMP, while the negative inotropism and lusitropism observed at higher concentrations were a-adrenergic-dependent. NOS inhibition abolished Myricetin-elicited vasodilation, also inducing Akt, ERK1/2 and eNOS phosphorylation in both ventricles and HUVEC. Myricetin-dependent vasodilation increases intracellular cGMP and is abolished by triton X-100. Abstract BACKGROUND AND AIMS: Moderate red wine consumption associates with lower incidence of cardiovascular diseases. Attention to the source of this cardioprotection was focused on flavonoids, the non-alcoholic component of the red wine, whose intake inversely correlates with adverse cardiovascular events. We analysed whether two red wine flavonoids, quercetin and myricetin, affect mammalian basal myocardial and coronary function. METHODS AND RESULTS: Quercetin and myricetin effects were evaluated on isolated and Langendorff perfused rat hearts under both basal conditions and alpha- and beta-adrenergic stimulation. The intracellular signalling involved in the effects of these flavonoids was analysed on perfused hearts and by western blotting on cardiac and HUVEC extracts. Quercetin induced biphasic inotropic and lusitropic effects, positive at lower concentrations and negative at higher concentrations. Contrarily, Myricetin elicits coronary dilation, without affecting contractility and relaxation. Simultaneous administration of the two flavonoids only induced vasodilation. Quercetin-elicited positive inotropism and lusitropism depend on beta1/beta2-adrenergic receptors and associate with increased intracellular cAMP, while the negative inotropism and lusitropism observed at higher concentrations were alpha-adrenergic-dependent. NOS inhibition abolished Myricetin-elicited vasodilation, also inducing Akt, ERK1/2 and eNOS phosphorylation in both ventricles and HUVEC. Myricetin-dependent vasodilation increases intracellular cGMP and is abolished by triton X-100. CONCLUSIONS: The cardiomodulation elicited on basal mechanical performance by quercetin and the selective vasodilation induced by myricetin point to these flavonoids as potent cardioactive principles, able to protect the heart in the presence of cardiovascular diseases.
- Published
- 2011
36. Development and validation of the Trust in Multidimensional Healthcare Systems Scale (TIMHSS).
- Author
-
Meyer SB, Brown P, Calnan M, Ward PR, Little J, Betini GS, Perlman CM, Burns KE, and Filice E
- Subjects
- Humans, Female, Male, Adult, Middle Aged, SARS-CoV-2, Surveys and Questionnaires, Pandemics, Trust, COVID-19, Delivery of Health Care standards, Delivery of Health Care methods
- Abstract
Context: The COVID-19 pandemic has reignited a commitment from the health policy and health services research communities to rebuilding trust in healthcare and created a renewed appetite for measures of trust for system monitoring and evaluation. The aim of the present paper was to develop a multidimensional measure of trust in healthcare that: (1) Is responsive to the conceptual and methodological limitations of existing measures; (2) Can be used to identify systemic explanations for lower levels of trust in equity-deserving populations; (3) Can be used to design and evaluate interventions aiming to (re)build trust., Methods: We conducted a 2021 review of existing measures of trust in healthcare, 72 qualitative interviews (Aug-Dec 2021; oversampling for equity-deserving populations), an expert review consensus process (Oct 2021), and factor analyses and validation testing based on two waves of survey data (Nov 2021, n = 694; Jan-Feb 2022, n = 740 respectively)., Findings: We present the Trust in Multidimensional Healthcare Systems Scale (TIMHSS); a 38-item correlated three-factor measure of trust in doctors, policies, and the system. Measurement of invariance tests suggest that the TIMHSS can also be reliably administered to diverse populations., Conclusions: This global measure of trust in healthcare can be used to measure trust over time at a population level, or used within specific subpopulations, to inform interventions to (re)build trust. It can also be used within a clinical setting to provide a stronger evidence base for associations between trust and therapeutic outcomes., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
37. Preliminary Evidence of the Differential Expression of Human Endogenous Retroviruses in Kawasaki Disease and SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children.
- Author
-
Balestrieri E, Corinaldesi E, Fabi M, Cipriani C, Giudice M, Conti A, Minutolo A, Petrone V, Fanelli M, Miele MT, Andreozzi L, Guida F, Filice E, Meli M, Grelli S, Rasi G, Toschi N, Torcetta F, Matteucci C, Lanari M, and Sinibaldi-Vallebona P
- Subjects
- Humans, Child, SARS-CoV-2 genetics, Interleukin-10 genetics, Pilot Projects, COVID-19 genetics, Endogenous Retroviruses genetics, Mucocutaneous Lymph Node Syndrome genetics
- Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a postinfectious sequela of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with some clinical features overlapping with Kawasaki disease (KD). Our research group and others have highlighted that the spike protein of SARS-CoV-2 can trigger the activation of human endogenous retroviruses (HERVs), which in turn induces inflammatory and immune reactions, suggesting HERVs as contributing factors in COVID-19 immunopathology. With the aim to identify new factors involved in the processes underlying KD and MIS-C, we analysed the transcriptional levels of HERVs, HERV-related genes, and immune mediators in children during the acute and subacute phases compared with COVID-19 paediatric patients and healthy controls. The results showed higher levels of HERV-W, HERV-K, Syn-1, and ASCT-1/2 in KD, MIS-C, and COV patients, while higher levels of Syn-2 and MFSD2A were found only in MIS-C patients. Moreover, KD and MIS-C shared the dysregulation of several inflammatory and regulatory cytokines. Interestingly, in MIS-C patients, negative correlations have been found between HERV-W and IL-10 and between Syn-2 and IL-10, while positive correlations have been found between HERV-K and IL-10. In addition, HERV-W expression positively correlated with the C-reactive protein. This pilot study supports the role of HERVs in inflammatory diseases, suggesting their interplay with the immune system in this setting. The elevated expression of Syn-2 and MFSD2A seems to be a distinctive trait of MIS-C patients, allowing to distinguish them from KD ones. The understanding of pathological mechanisms can lead to the best available treatment for these two diseases, limiting complications and serious outcomes.
- Published
- 2023
- Full Text
- View/download PDF
38. Informing efforts beyond tailored promotional campaigns by understanding contextual factors shaping vaccine hesitancy among equity-deserving populations in Canada: an exploratory qualitative study.
- Author
-
Nascimento LG, Dubé È, Burns KE, Brown P, Calnan M, Ward PR, Filice E, Herati H, Ike NAU, Rotolo B, and Meyer SB
- Subjects
- Humans, Canada, Vaccination Hesitancy, Government, Vaccination, COVID-19 Vaccines, COVID-19 prevention & control
- Abstract
Background: Vaccine hesitancy exists on a continuum ranging between complete adherence and complete refusal due to doubts or concerns within a heterogeneous group of individuals. Despite widespread acknowledgement of the contextual factors influencing attitudes and beliefs shaping COVID-19 vaccine hesitancy, qualitative research with equity-deserving groups, accounting for unique lived experiences, remains a gap in the literature. We aim to identify and begin to understand and document the unique contextual factors shaping hesitancy by equity-deserving groups as it relates to relationships with government and health authorities., Methods: Participants were recruited and interviewed between Aug-Dec 2021. Semi-structured interviews using a convergent interviewing technique were conducted with individuals from the general population, as well as individuals who identify as First Nations, Métis, or Inuit, members of the LGBT2SQ + community, low-income Canadians, Black Canadians, and newcomers. Interviews were audio recorded and transcribed by a team of researchers. Memos were written following interviews and used to complement the thematic analysis of the interview data. Themes are presented in the results section., Results: The rationale for hesitancy among equity-deserving groups is consistent with literature documenting hesitancy in the general population. Contextual factors surrounding equity-deserving groups' attitudes and beliefs, however, are unique and relate to a history of oppression, discrimination, and genocide. We identified factors unique to subgroups; for example, religious or fatalistic beliefs among participant who identify as FNMI, fear associated with lack of testing and speed of vaccines' production among participants who identify as FNMI, Black, and LGBT2SQ + , distrust of the healthcare system for LGBT2SQ + and Black Canadians, and distrust of the government and opposition to vaccine mandates for participating who identify as LGBT2SQ + , low-income, FNMI, or Black Canadian. Newcomers stood out as very trusting of the government and accepting of COVID-19 vaccination., Conclusions: While our data on vaccine hesitancy largely mirror concerns reported in the vast body of literature citing rationale for COVID-19 hesitancy in high-income countries, the contextual factors identified in our work point to the need for wider systemic change. Our results may be used to support efforts, beyond tailored promotion campaigns, to support the confident acceptance of vaccines for COVID-19 and the acceptance of novel vaccines as future infectious diseases emerge., (© 2023. BioMed Central Ltd., part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
39. Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use.
- Author
-
Conti F, Moratti M, Leonardi L, Catelli A, Bortolamedi E, Filice E, Fetta A, Fabi M, Facchini E, Cantarini ME, Miniaci A, Cordelli DM, Lanari M, Pession A, and Zama D
- Subjects
- Humans, Child, Anti-Inflammatory Agents therapeutic use, SARS-CoV-2, Immunomodulation, Off-Label Use, Immunoglobulins, Intravenous therapeutic use
- Abstract
Background: The large-scale utilization of immunoglobulins in patients with inborn errors of immunity (IEIs) since 1952 prompted the discovery of their key role at high doses as immunomodulatory and anti-inflammatory therapy, in the treatment of IEI-related immune dysregulation disorders, according to labelled and off-label indications. Recent years have been dominated by a progressive imbalance between the gradual but constant increase in the use of immunoglobulins and their availability, exacerbated by the SARS-CoV-2 pandemic., Objectives: To provide pragmatic indications for a need-based application of high-dose immunoglobulins in the pediatric context., Sources: A literature search was performed using PubMed, from inception until 1st August 2023, including the following keywords: anti-inflammatory; children; high dose gammaglobulin; high dose immunoglobulin; immune dysregulation; immunomodulation; immunomodulatory; inflammation; intravenous gammaglobulin; intravenous immunoglobulin; off-label; pediatric; subcutaneous gammaglobulin; subcutaneous immunoglobulin. All article types were considered., Implications: In the light of the current imbalance between gammaglobulins' demand and availability, this review advocates the urgency of a more conscious utilization of this medical product, giving indications about benefits, risks, cost-effectiveness, and administration routes of high-dose immunoglobulins in children with hematologic, neurologic, and inflammatory immune dysregulation disorders, prompting further research towards a responsible employment of gammaglobulins and improving the therapeutical decisional process.
- Published
- 2023
- Full Text
- View/download PDF
40. Canadians' trust in government in a time of crisis: Does it matter?
- Author
-
Herati H, Burns KE, Nascimento M, Brown P, Calnan M, Dubé È, Ward PR, Filice E, Rotolo B, Ike N, and Meyer SB
- Subjects
- Humans, Canada, COVID-19 epidemiology, Government, Pandemics, Trust
- Abstract
The ability of governments and nations to handle crises and protect the lives of citizens is heavily dependent on the public's trust in their governments and related social institutions. The aim of the present research was to understand public trust in government during a time of crisis, drawing on interview data (N = 56) collected during the COVID-19 pandemic (2021). In addition to the general public (n = 11), participants were sampled to obtain diversity as it relates to identifying as First Nations, Métis, and Inuit (n = 7), LGBT2SQ+ (n = 5), low-income (n = 8), Black Canadians (n = 7), young adult (n = 8), and newcomers to Canada (n = 10). Data were coded in consideration of social theories of trust, and specifically the nature of trust between individuals and institutions working with government in pandemic management. Canadians' trust in government was shaped by perceptions of pandemic communication, as well as decision-making and implementation of countermeasures. Data suggest that although participants did not trust government, they were accepting of measures and messages as presented through government channels, pointing to the importance of (re)building trust in government. Perhaps more importantly however, data indicate that resources should be invested in monitoring and evaluating public perception of individuals and institutions generating the evidence-base used to guide government communication and decision-making to ensure trust is maintained. Theoretically, our work adds to our understanding of the nature of trust as it relates to the association between interpersonal and institutional trust, and also the nature of trust across institutions., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2023 Herati et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
41. "I Want People to Be Able to Make an Informed Choice": How Quebec naturopaths discuss vaccination in their practice.
- Author
-
Malo B, Labbé F, Meyer SB, Filice E, Graham JE, MacDonald NE, Bettinger JA, Greyson D, MacDonald SE, Driedger SM, Kawchuk G, and Dubé E
- Subjects
- Humans, Quebec, Canada, Vaccination, Complementary Therapies, Naturopathy
- Abstract
Health care providers' recommendations can play an important role in individuals' vaccination decisions. Despite being one of the most popular complementary and alternative medicine (CAM), naturopathy is understudied in relation to vaccination decisions. We sought to address this gap through this study of vaccination perspectives of naturopathy practitioners in the province of Quebec, Canada. We conducted in-depth interviews with 30 naturopaths. Thematic analysis was conducted. Main themes were developed deductively (i.e., based on prior literature) and expanded through inductive coding of the data. Participants noted that they discuss vaccination in their practice, but only when clients asked questions or wanted advice. Naturopaths described refraining from explicitly recommending for or against vaccination. Instead, they focus on empowering their clients to make their own informed decision regarding vaccination. Most participants noted that they direct clients towards sources of information so that clients could decide for themselves, but some mentioned they discussed with clients what they considered to be risks associated with vaccination, as well as its benefits. These discussions were framed through a personalized and individual approach with clients., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
42. Newcomer perceptions of COVID-19 countermeasures in Canada.
- Author
-
Koshy L, Burns K, Godinho Nascimento MH, Ike NAU, Herati H, Filice E, Rotolo B, Betini GS, Ward PR, Dubé È, and Meyer SB
- Subjects
- Humans, Canada epidemiology, COVID-19 prevention & control
- Abstract
Newcomers to Canada have been disproportionally affected by COVID-19, with higher rates of infection and severity of illness. Determinants of higher rates may relate to social and structural inequities that impact newcomers' capacity to follow countermeasures. Our aim was to describe and document factors shaping newcomers' acceptance of COVID-19 countermeasures. Semi-structured qualitative interviews were conducted with individuals living in Canada for <5 years. Participants were asked to discuss their pandemic experiences, and perceptions and acceptance of measures. Five themes were identified: (i) belief in the necessity and efficacy of countermeasures; (ii) negative impact of measures on health/wellbeing; (iii) existing barriers to newcomer settlement exacerbated by pandemic measures; (iv) countermeasure adherence related to immigration status and (v) past experiences shaping countermeasure acceptance. Government should continue to provide messaging regarding the importance of measures for individual and population heath and continue to demonstrate a commitment to the interests of citizens. Importantly, newcomer trust in government should not be taken for granted, as this trust is critical for the acceptance of government interventions now and moving forward. It will be important to ensure that newcomers are given support to overcome challenges to settlement that were intensified during the pandemic., (© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
43. Examining factors impacting acceptance of COVID-19 countermeasures among structurally marginalised Canadians.
- Author
-
Ike N, Burns KE, Nascimento H, Filice E, Ward PR, Herati H, Rotolo B, Betini GS, Perlman CM, and Meyer SB
- Subjects
- Humans, Canada epidemiology, Delivery of Health Care, Poverty, Pandemics, COVID-19 epidemiology
- Abstract
The COVID-19 pandemic highlighted and exacerbated inequities in health for structurally marginalised Canadians. Their location on society's hierarchies constrained their ability to access healthcare and follow recommended health behaviours. The aim of this article is to identify, from the perspective of marginalised populations, factors influencing the acceptance or rejection of COVID-19 countermeasures by structurally marginalised Canadians. Interviews were conducted with Canadians 18 + who identified as Black (n = 8), First Nations, Métis, or Inuit (n = 7) and low-income (<40,000 annual household income) (n = 8) between August and December 2021. Measures were said to impact well-being and interfere with revenue generating activities. Longstanding unfavourable living and environmental conditions as they relate to structural marginalisation was said to fuel anger toward the government and lead to a greater reluctance to accept countermeasures. Participants described concerns about government decisions being made without considering their unique contexts, or knowledge of the experiences of the population for whom these decisions were being made. Effective proactive action from government is important to foster trust with marginalised populations to support acceptance of health information and address growing inequities. Action that demonstrates government competence and commitment to the interests of marginalised populations is critical.
- Published
- 2023
- Full Text
- View/download PDF
44. A practical nutritional guideline to manage neuroendocrine neoplasms through chronotype and sleep.
- Author
-
Muscogiuri G, Zanata I, Barrea L, Cozzolino A, Filice E, Messina E, Colao A, and Faggiano A
- Subjects
- Humans, Chronotype, Sleep physiology, Circadian Rhythm, Life Style, Surveys and Questionnaires, Metabolic Syndrome, Neuroendocrine Tumors
- Abstract
Chronotype is the attitude of subjects to carry out their daily activities mainly in the morning ("lark") or in the evening ("owl"). The intermediate chronotype is located between these two categories. It has been demonstrated that chronotype can influence the incidence, course and response to treatments of tumors. In particular patients diagnosed with gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) and evening chronotype are characterized by unhealthy lifestyle, obesity, metabolic syndrome, a worsen cardiometabolic profile, a poor prognosis with a progressive disease and the development of metastasis. In addition, evening chronotype has been associated with sleep disturbances, which in turn have been related to tumor development and progression of tumors. There is a strict connection between sleep disturbances and NENs because of the hyperactivation of proangiogenic factors that caused aberrant neoangiogenesis. A nutritional tailored approach could represent a tool to align subjects with evening chronotype to physiological biological rhythms based on the properties of some macro and micronutrients of being substrate for melatonin synthesis. Thus, we aimed to provide an overview on the association of chronotype categories and sleep disturbances with NENs and to provide nutritional advices to manage subjects with NENs and these disturbances of circadian rhythm.
- Published
- 2023
- Full Text
- View/download PDF
45. Shades of digital deception: Self-presentation among men seeking men on locative dating apps.
- Author
-
Filice E, Johnson CW, Parry DC, and Oakes H
- Abstract
In recent years, location-based real-time dating apps like Grindr and Tinder have assumed an increasingly pivotal role in brokering socio-sexual relations between men seeking men and have proven to be fertile ground for the study of identity negotiation and impression management. However, current research has given insufficient consideration to how various contextual elements of technology use interact with one another to shape self-presentation behaviour. Through analysis of interview data, we found impression construction on these apps reflects tensions between authentic depiction of the self-concept and self-enhancement via deception. Whether and the extent to which one engages in deception depends on how a number of technological affordances, platform-specific community norms and userbase characteristics interact with each other. Self-presentational choices were a result of a combination of deception facilitators, for example, belief in the normalcy of lying, and constraining determinants, for example, the expectation of brokering physical connection. Impression construction determinants also interact in ways where the influence of any one element is dependent on others. This was most plainly evidenced in the interactions between stigma management concerns, the affordances of audience visibility/control and locatability and common ground reinforcing social hierarchy., Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article., (© The Author(s) 2022.)
- Published
- 2022
- Full Text
- View/download PDF
46. Psoriasis and Cardiovascular Risk in Children: The Usefulness of Carotid Intima-Media Thickness.
- Author
-
Fabi M, Chessa MA, Panizza D, Dormi A, Gazzano A, Patrizi A, Bardazzi F, Rocca A, Filice E, Neri I, and Lanari M
- Subjects
- Adult, Carotid Arteries diagnostic imaging, Carotid Intima-Media Thickness, Child, Glucose, Heart Disease Risk Factors, Humans, Risk Factors, Triglycerides, Cardiovascular Diseases epidemiology, Cardiovascular Diseases etiology, Psoriasis complications
- Abstract
Psoriasis is a skin disorder which mostly affects adults, beginning in childhood in almost one-third of patients. In adults it is associated with increased risk for cardiovascular diseases (CVD), while this association is still debated at younger age. Our aim was to evaluate the association between psoriasis and metabolic markers and cardiovascular findings in this age group. Twenty consecutive patients previously diagnosed with psoriasis (group A) were enrolled and compared with healthy non- psoriatic age- and sex-matched subjects (group B). The severity of the disease, CV risk factors, including anthropometric data with adiposity and its distribution, blood pressure (BP), laboratory metabolic tests, echocardiography and vascular ultrasound (transcranial echo-Doppler and carotid artery echo-Doppler with carotid intima-media thickness, cIMT) were performed for each subject. Personal history for CV risk, BP, anthropometric data were similar between the two groups, while familiar history for psoriasis was more frequent in group A (p < 0.02). C-IMT was significantly higher in group A compared to B (right, p = 0.001; left, p = 0.002). In addition, c-IMT was positively correlated with disease duration, triglycerides and triglycerides/glucose. Cerebral flow velocities, cardiac measurements, systo-diastolic function, ventricle geometry and mass were normal and comparable between the two groups, and did not correlate with CV risk factors. In childhood psoriasis c-IMT could represent a marker of pre-clinical cardiovascular involvement and contribute to start a personalized management, while cardiac findings seem to be normal in the early stage of disease. Longitudinal studies can clarify the progression of CV involvement in paediatric-onset psoriasis., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
47. Circulating Endothelial Cells: A New Possible Marker of Endothelial Damage in Kawasaki Disease, Multisystem Inflammatory Syndrome in Children and Acute SARS-CoV-2 Infection.
- Author
-
Fabi M, Petrovic B, Andreozzi L, Corinaldesi E, Filice E, Biagi C, Rizzello A, Mattesini BE, Bugani S, and Lanari M
- Subjects
- Biomarkers, Child, Endothelial Cells pathology, Humans, Prospective Studies, SARS-CoV-2, Systemic Inflammatory Response Syndrome complications, Systemic Inflammatory Response Syndrome diagnosis, COVID-19 complications, Mucocutaneous Lymph Node Syndrome complications, Mucocutaneous Lymph Node Syndrome diagnosis, Vascular System Injuries
- Abstract
Background: Kawasaki Disease (KD) and Multisystem Inflammatory Syndrome in Children (MIS-C) are pediatric diseases characterized by systemic inflammation and vascular injury, potentially leading to coronary artery lesions (CALs). Data on vascular injury occurring during acute COVID-19 (AC19) in children are still lacking. The aim of our study was to investigate endothelial injury in KD-, MIS-C- and AC19-dosing circulating endothelial cells (CECs)., Methods: We conducted a multicenter prospective study. CECs were enumerated by CellSearch technology through the immunomagnetic capture of CD146-positive cells from whole blood., Results: We enrolled 9 KD, 20 MIS-C and 10 AC19. During the acute stage, the AC19 and KD patients had higher CECs levels than the MIS-C patients. From the acute to subacute phase, a significant CEC increase was observed in the KD patients, while a mild decrease was detected in the MIS-C patients. Cellular clusters/syncytia were more common in the KD patients. No correlation between CECs and CALs were found in the MIS-C patients. The incidence of CALs in the KD group was too low to investigate this correlation., Conclusions: Our study suggests a possible role of CECs as biomarkers of systemic inflammation and endothelial dysfunction in KD and MIS-C and different mechanisms of vascular injury in these diseases. Further larger studies are needed.
- Published
- 2022
- Full Text
- View/download PDF
48. Gut Microbiota Dysbiosis in Childhood Vasculitis: A Perspective Comparative Pilot Study.
- Author
-
Fabi M, D'Amico F, Turroni S, Andreozzi L, Filice E, Brigidi P, and Lanari M
- Abstract
Kawasaki disease (KD) and Henoch-Schönlein purpura (HSP) are the most frequent vasculitis in childhood. For both, a multifactorial mechanism has been hypothesised, with an abnormal immune response in genetically predisposed children. Gut microbiota (GM) alterations might trigger the hyperimmune reaction. Our aim was to explore the GM in KD and compare it with the GM of HSP and febrile children. Children diagnosed with KD, HSP and non-KD febrile illness (F) were enrolled. GM was profiled by 16S rRNA gene sequencing and compared with the profiles of healthy children from previous studies. We enrolled 13 KD, 10 HSP and 12 F children. Their GM significantly differed from controls, with an overall reduction in the relative abundance of beneficial taxa belonging to the Ruminococcaceae and Lachnospiraceae families. Potential KD and HSP signatures were identified, including smaller amounts of Dialister in the former, and Clostridium and Akkermansia in the latter. Notably, the GM structures of KD, HSP and F patients stratified by abdominal involvement, with more severe dysbiosis in those suffering from intestinal symptoms. This is the first study analysing GM in a mostly Caucasian cohort of KD and HSP children. Our data could open up new opportunities for childhood vasculitis treatment.
- Published
- 2022
- Full Text
- View/download PDF
49. Combination of fecal calprotectin and initial coronary dimensions to predict coronary artery lesions persistence in Kawasaki disease.
- Author
-
Fabi M, Filice E, Andreozzi L, Mattesini BE, Rizzello A, Palleri D, Dajti E, Zagari RM, and Lanari M
- Subjects
- C-Reactive Protein metabolism, Child, Child, Preschool, Coronary Vessels metabolism, Female, Humans, Immunoglobulins, Intravenous, Infant, Leukocyte L1 Antigen Complex, Male, Prospective Studies, Coronary Artery Disease diagnosis, Mucocutaneous Lymph Node Syndrome complications, Mucocutaneous Lymph Node Syndrome diagnosis
- Abstract
Kawasaki Disease (KD) is systemic vasculitis involving medium-sized vessels in children. The aim of our study is to determine if fecal calprotectin (FC) could be useful in predicting the development or persistence of coronary artery lesions (CALs) in KD. We conducted a prospective monocentric study including all consecutive diagnoses of. Clinical, laboratory, echocardiographic data were recorded during the acute and subacute phase, including FC. Correlations among laboratory values, FC, clinical manifestations, IVIG-responsiveness and CALs development were investigated. We enrolled 26 children (76.9% boys; median age 34.5 months). The combination of FC > 250 microg/g and z-score > 2 during the acute phase was associated with the persistence of CALs (p = 0.022). A z-score > 2 alone during the acute phase was not related to CALs during the subacute stage (p > 0.05). A neutrophil percentage > 70% and WBC > 15,000/mmc during the acute phase significantly correlated with the presence of CALs during the subacute phase (p = 0.008). C-reactive protein (CRP) > 13 mg/dL at KD onset was significantly associated with the presence of CALs during the acute (p = 0.017) and subacute phase (p = 0.001). The combination of FC > 250 microg/g and a z-score > 2 during the acute phase of KD may be used as a predictor of CALs persistence. It can be useful especially in children with an initial CRP < 13 mg/dl., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
50. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
- Author
-
Fabi M, Filice E, Biagi C, Andreozzi L, Palleri D, Mattesini BE, Rizzello A, Gabrielli L, Ghizzi C, Di Luca D, Caramelli F, De Fanti A, and Lanari M
- Subjects
- Adolescent, COVID-19 diagnosis, COVID-19 epidemiology, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Infant, Infant, Newborn, Interleukin-10 blood, Interleukin-8 blood, Italy epidemiology, Male, Mucocutaneous Lymph Node Syndrome diagnosis, Prospective Studies, SARS-CoV-2 metabolism, Systemic Inflammatory Response Syndrome diagnosis, Systemic Inflammatory Response Syndrome epidemiology, Ventricular Dysfunction, Left virology, COVID-19 complications, COVID-19 pathology, Mucocutaneous Lymph Node Syndrome pathology, Myocardium pathology, Systemic Inflammatory Response Syndrome pathology, Ventricular Dysfunction, Left pathology
- Abstract
SARS-CoV-2 infection in children can trigger cardiovascular manifestations potentially requiring an intensive treatment and defining a new entity named Multisystem Inflammatory Syndrome in Children (MIS-C), whose features partially overlap with Kawasaki Disease (KD). A cross-sectional study including all diagnoses of MIS-C and KD from April 2020 to May 2021 in our metropolitan area was conducted evaluating clinical, laboratory (including immunological response, cytokines, and markers of myocardial damage), and cardiac (coronary and non-coronary) features at onset of the diseases. Evolution of ventricular dysfunction, valve regurgitations, and coronary lesions was documented. The severity of the disease was also considered based on the need for inotropic support and ICU admission. Twenty-four MIS-C were diagnosed (14 boys, median age 82 months): 13/24 cases (54.17%) presented left ventricular dysfunction, 12/24 (50%) required inotropic support, and 10/24 (41.67%) developed coronary anomalies (CALs). All patients received steroids and IVIG at a median time of 5 days (IQR1:4, IQR3:6.5) from onset of fever and heart function normalized 6 days (IQR1: 5, IQR3: 7) after therapy, while CALs persisted in one. One patient (12.5%) required infliximab because of refractory disease and still presented CALs 18 days after therapy. During the same study period, 15 KD were diagnosed: none had ventricular dysfunction, while 7/15 (46.67%) developed CALs. Three out of 15 patients (20%) still presented CALs 46 days from onset. Compared to KD, MIS-C pts have significantly higher IL8 and similar lymphocytes subpopulations. Despite a more severe presentation and initial cardiac findings compared to KD, the myocardial injury in MIS-C has a rapid response to immunomodulatory treatment (median time 6 days), in terms of ventricular function, valve regurgitations, and troponin. Incidence of CALs is similar at onset, but it tends to regress in most of the cases of MIS-C differently than in KD where CALs persist in up to 40% in the subacute stage after treatment.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.